EPS8 and hearing loss disorder: We speculate that, for genes involved in the early stages of morphological and functional development of cochlear hair cells, there is a critical window for successful therapeutic gene delivery for treating hearing loss, and, in some cases (e.g., EPS8 and some Usher proteins), in utero delivery of genes via AAVs may be required as previously performed for other genes.73